What is the ticker symbol for Palisade Bio?

Palisade Bio trades under the ticker PALI on NASDAQ.

What sector does Palisade Bio operate in?

Palisade Bio is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze PALI in a portfolio?

PortView shows PALI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Palisade Bio (PALI) Stock Analysis

NASDAQHealthcareBiotechnology

$1.97+0.27%

1-year price historyRange $0.54 – $2.80

52-week range$1.97

$0.53$2.86

What Palisade Bio does

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, engages in developing oral phosphodiesterase-4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon in the United States. Its lead clinical product candidate includes PALI-2108, which is in phase 1b clinical trial to treat patients with inflammatory bowel disease, including ulcerative colitis and Fibrostenotic Crohn’s disease. The company has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company was founded in 2001 and is headquartered in Denver, Colorado.

Key metrics

Market cap

$341.12M

P/E (TTM)

-1.87

EPS (TTM)

$-1.05

Beta

1.54

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$2.02

200-day avg

$1.94

52-week high

$2.86

52-week low

$0.53

CEO

J. D. Finley

ETFs linked to PALI

Broad-market and Healthcare sector ETFs an investor holding Palisade Bio is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how PALI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PALI in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Palisade Bio?: Palisade Bio trades under the ticker PALI on NASDAQ.
Which exchange is PALI listed on?: PALI is listed on NASDAQ.
What sector does Palisade Bio operate in?: Palisade Bio is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze PALI in a portfolio?: PortView shows PALI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.